As a case in point, BMP4 was identified as a compelling candidate molecule promoting NB cell line differentiation, exhibiting the capacity to decrease expression of CD15 and CD184 antigens as well as the neuroblast marker DCX and malignancy-associated NMYC, while simultaneously enhancing TrkA expression. This evidence concerns the gene CXCR4 and neuroblastoma.